Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Share:
Related MYL
Paulson & Company's Q4 Moves: Healthcare And Beyond
Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR
Notable earnings after Monday's close (Seeking Alpha)
Related SLXP
Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity
Notable earnings after Monday's close (Seeking Alpha)

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

Posted-In: Drugs-Generic Industry highest cash NASDAQ StocksTrading Ideas

 

Related Articles (AKRX + HITK)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→